Erlotinib in Treating Patients With Advanced Kidney Cancer

NCT00045487 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators